- Lobbying
- Lobbying by National Trauma Institute
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Nicole Di Resta | Prof. Staff Member- Senate Approps. Committee, Chair. Inouye LA, Sen. Shumer, LA Cong. Shumer, LA/LC/SA Cong. Markey - PSM Sen Comm Appropriations, Chairman Inouye LA/Sen &Cong Shumer, LA/LC/SA Rep Markey Professional Staff, Senate Appropriations Cmte. |
Michelle Greene | Ch Ch, Cong Affairs, OTSG; Army Lia FM&C DepSurgGen,OTSG;Dep CH, Pt Adm, Tripler AMC Dep Ch, Pt Adm, Winn Hosp Ch Ch, Cong Affairs, OTSG; Army Lia FM&C; DepSurgGen,OTSG; Dep CH, Pt Adm, Tripler AMC; Pt Adm, Clin Ops, NARMC; Co Cdr, Walter Reed; Dep Ch, Pt Adm, Winn Hosp Pt Adm, Clin Ops, NARMC; Co Cdr, Walter Reed Ch, Cong Affairs, OTSG; Army Cong Lia FM&C |
Mihcelle Greene | Pt Adm, Clin Ops, NARMC; Co Cdr, Walter Reed |
Rebecca Middleton | Senior Legislative Asst-Rep. Frank Wolf |
Nicole DiResta | Professional Staff, Senate Appropriations Cmte. LA/Sen &Cong Shumer, LA/LC/SA Rep Markey |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
White House Office
Homeland Security - Dept of (DHS)
Federal Bureau of Investigation (FBI)
Natl Institutes of Health (NIH)
Transportation - Dept of (DOT)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
White House Office
Federal Bureau of Investigation (FBI)
Natl Institutes of Health (NIH)
Homeland Security - Dept of (DHS)
Transportation - Dept of (DOT)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
White House Office
Homeland Security - Dept of (DHS)
Federal Bureau of Investigation (FBI)
Natl Institutes of Health (NIH)
Transportation - Dept of (DOT)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
White House Office
Federal Bureau of Investigation (FBI)
Natl Institutes of Health (NIH)
Homeland Security - Dept of (DHS)
Transportation - Dept of (DOT)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
White House Office
Homeland Security - Dept of (DHS)
Federal Bureau of Investigation (FBI)
Natl Institutes of Health (NIH)
Transportation - Dept of (DOT)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
White House Office
Federal Bureau of Investigation (FBI)
Natl Institutes of Health (NIH)
Homeland Security - Dept of (DHS)
Transportation - Dept of (DOT)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Defense - Dept of (DOD)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Defense - Dept of (DOD)
Type of Issue
Defense
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Defense - Dept of (DOD)
Type of Issue
Defense
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Defense - Dept of (DOD)
Type of Issue
Defense
Registration
Issue(s) they said they’d lobby about: Clinical trauma research.
Termination
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Termination
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Clinical trauma research.
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
U.S. Senate
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate